InterestingFACT
Bluelighter
- Joined
- Nov 18, 2013
- Messages
- 512
I'm excited to hear your report on DOPR--I've yet to try a DOX other than DOC. The fact that you captured a gram and a half of raw is what really interests me, because I just can never justify to myself the cost for chemicals on blotter. I'll have to peruse my sources.Definitely a small feeling so far... it feels really good, actually significantly more comfortable than early DOC feeling, absolutely no edginess right now or excess energy, just a nice, smooth, velvety feeling.
EDIT at 12:11 - Appetite and work are not affected, about to eat various things as I'm hungry. My patience at work is actually improved. When I've taken even .5mg of DOC before when working, I don't really like it, it's a bit distracting and the energy is uncomfortable when I have to sit here. This seems to be giving me no energy other than a bit of motivation and a clearheaded feeling, and my mood is improved. it's a really nice feeling, incredibly smooth and just a bit euphoric. This bodes very well for a full dosage, I'm even more excited for that now.Probably in 2 weekends. oh and also I am hopefully going to the Lockn music festival (Santana, Robert Plant, and John Popper (from Blues Traveler) will be there, and Derek Trucks, and a bunch of other great things... I'm trying to volunteer to get in free) in early September and I bet a fairly high dose of this might be good there... I'll see after my 4mg dose which is coming next).
--
It's also a clear sign that I haven't been "keeping up with the joneses" on bluelight that I don't have a clue who this Metanoiaman fellow is... These days I pretty much just read new posts in my subscribed threads from my phone. I'll just say this: "natural" certainly doesn't mean "better" but "natural with a long history of human use" generally does mean "generally recognizable as safe." Especially when considering that most RCs are the product of very preliminary research--ie. as part of a search for more selective or efficacious ligands, or as a permutation in a systematic receptor-mapping effort--the resulting high potency, high affinity, high efficacy ligands often have unusual structures not comparable to biological products and are therefore less likely to be metabolized into familiar byproducts... it's not that it matters whether a particular drug is "synthetic," but the degree to which a ligand exhibits deviation from existing well-understand and biologically familiar scaffolds does relate in some way to the conferred "unknown risks" we assume when we ingest this ligand.